The nation of Zimbabwe has rejected a significant American health deal worth $367m (£272m) over five years because of the United States' insistence on sensitive information.
This rejection became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman has since explained that the United States was requesting genetic material for research and commercial purposes but refused to guarantee the benefits from future treatments.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more talks to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Background
Zimbabwe's decision comes after a similar situation in Kenya, where a high court suspended a similar deal with the US following concerns were raised about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date signed similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to provide its biological resources and data for a long time, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our citizens should a future pandemic arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks previously set up through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This framework is intended to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks should continue given that much of the country's Aids initiatives were funded by international support.
"Where technical issues arise, such as those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it said.
This impasse emphasises the continuing challenges between accepting crucial international aid and safeguarding local interests in an increasingly data-driven world.